The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia.
about
Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapyInsights on neoplastic stem cells from gel-based proteomics of childhood germ cell tumorsThe SWI/SNF genetic blockade: effects in cell differentiation, cancer and developmental diseasesNovel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populationsDeletion of Arid1a in Reproductive Tract Mesenchymal Cells Reduces Fertility in Female Mice.Bim polymorphisms: influence on function and response to treatment in children with acute lymphoblastic leukemia.Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cellsTargeting Transcription Factors in CancerPharmacogenomics in pediatric leukemia.miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1.Pharmacogenetics in acute lymphoblastic leukemia.Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium.Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer.Pharmacogenomics in acute myeloid leukemia.Pharmacogenomics of pediatric acute lymphoblastic leukemia.Protein kinase networks regulating glucocorticoid-induced apoptosis of hematopoietic cancer cells: fundamental aspects and practical considerations.Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia.Epigenomic regulation of oncogenesis by chromatin remodeling.BRG1 regulation by miR-155 in human leukemia and lymphoma cell lines.The roles of SNF2/SWI2 nucleosome remodeling enzymes in blood cell differentiation and leukemiaA population-based single nucleotide polymorphism array analysis of genomic aberrations in younger adult acute lymphoblastic leukemia patients.Molecular pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer--mechanisms and potential therapeutic insights.Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease.Curing acute lymphoblastic leukemia and avoiding osteonecrosis: can't we have it all?Sensitization of retinoids and corticoids to epigenetic drugs in MYC-activated lung cancers by antitumor reprogramming.Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations.
P2860
Q28083449-9335BD5E-27B0-4B34-8AA2-DE0E3E6A15E2Q28244211-9886C8DB-E69F-4CAC-B3AB-2F7C44CAD8DDQ28292392-72B1342C-CC01-4E34-AE3F-AC1444F2BFFEQ28943485-81A7043D-6E2B-460A-9573-2F7AD3058BF5Q30353348-F409BA7D-32CB-4A2C-80CD-24F14A3EC109Q34026481-0FF0FAAB-4034-4AE2-AE84-B3549158A3D8Q34388531-134E362E-D576-41DE-B6DC-BAD7295E8E32Q35665990-6A254716-64B5-4A4C-976E-4F667AD451A2Q36347511-DD5CE209-6228-4BFA-A3FA-2E3D5B40DA65Q36727952-4EF0F376-99D3-4537-885D-B115D09A6A90Q37040632-5B489D50-65E1-4DF8-8B05-B609177B05BBQ37150913-C62005B4-3F57-4EBF-88DA-26A7783D0CD1Q37389731-23724F7C-919E-41C6-8D4F-C1F0A0D31573Q37457993-BA413FFA-B8C3-427A-9087-205D84FC331FQ37618471-B598293F-A2A5-4711-BAF9-8137C19E3567Q37627876-26EF2F92-B365-4448-B591-0A9F1F5A6109Q37739432-08C76970-4036-400C-B443-62A55FD836BDQ37789771-C6E7519A-130D-476F-90A8-41DC55B0C98FQ38075561-3D98F4A7-1CBA-411A-ACB0-484E98B34B51Q38709544-5A8C6A76-4547-4EE1-8C7C-950171EF1A8AQ38714250-5AEA453A-513F-48E3-A1FD-06F776F81B8CQ41194172-7849EE61-47CB-4580-8939-7C72D0D4B9B3Q41366254-D1FDDD9F-A057-4535-B1B0-5483299FB569Q42416688-0E116560-F914-4D18-BED2-73ED89CFFF8FQ42703436-E0BE70D0-B751-4C4D-A621-410704CB1375Q44622169-978D8250-9FA6-4E93-9B91-FB3D2EDBC8ABQ49068138-5F6A066D-8B89-4CC3-AAC5-509F2294FE00Q54213148-A054BED3-0568-424B-99B8-555C47603C80
P2860
The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The SWI/SNF chromatin-remodeli ...... acute lymphoblastic leukemia.
@en
The SWI/SNF chromatin-remodeli ...... acute lymphoblastic leukemia.
@nl
type
label
The SWI/SNF chromatin-remodeli ...... acute lymphoblastic leukemia.
@en
The SWI/SNF chromatin-remodeli ...... acute lymphoblastic leukemia.
@nl
prefLabel
The SWI/SNF chromatin-remodeli ...... acute lymphoblastic leukemia.
@en
The SWI/SNF chromatin-remodeli ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P50
P356
P1476
The SWI/SNF chromatin-remodeli ...... n acute lymphoblastic leukemia
@en
P2093
Cheng Cheng
Deqing Pei
John C Panetta
Mahfoud Assem
Mary V Relling
Monique L Den Boer
Rob Pieters
Wenjian Yang
William E Evans
P2860
P304
P356
10.1093/JNCI/DJN416
P407
P577
2008-12-09T00:00:00Z